Abstract:Background. Higher body mass index (BMI) is associated with poor survival after breast cancer diagnosis. BMI is a heritable trait. A polygenic risk score (PRS) for BMI has been associated with cardiometabolic traits and found to modify weight loss interventions. Whether BMI genetic scores affect survival in women with breast cancer is unknown. Methods. This analysis was conducted in the Cancer Prevention Study II Nutrition cohort. Women diagnosed with non-metastatic breast cancer between 1992 and 2017 were included in the analysis if they had genotype data. Analyses were restricted to unrelated, postmenopausal women at the time of diagnosis who were of European ancestry (N=3,566). Deaths through 2020 were identified through linkage with the National Death Index. Primary cause of death was based on the International Classification of Disease codes. Pre-diagnosis BMI was self-reported (median 1.3 years from BMI measurement to diagnosis, interquartile range (IQR): 0.6, 1.9). We constructed a PRS using findings from a published meta-analysis of BMI genome wide association studies (GWAS) that included ~700,000 individuals and the PRSice tool.Hazard ratios (HR) and 95% confidence intervals (CI) between the PRS and all-cause mortality were estimated using Cox proportional hazards regression and Fine and Gray models for cause-specific mortality to account for competing risks. Models were adjusted for age and GWAS-specific statistically significant (P<0.05) principal components for population stratification. Mediation was estimated using the mediation R package. Results. The median age at diagnosis was 71.5 years (IQR: 66.3, 76.8). Most women were overweight (33.5%) or obese (18.4%) and were diagnosed with localized stage (63%) and estrogen receptor positive (65%) breast cancer. During a median follow-up of 14.5 years (IQR: 9.7-19.8), there were 1,825 (51.2%) deaths, including 301 breast cancer and 337 cardiovascular disease (CVD) specific deaths. In multivariable models, a 5 Kg/m2 increase in BMI was associated with increased risks of all-cause mortality (HR=1.09, 95% CI: 1.04, 1.15), breast cancer-specific mortality (HR=1.27, 95% CI: 1.13, 1.42), and CVD-specific mortality (HR=1.25, 95% CI: 1.11, 1.41). The PRS was highly predictive of pre-diagnostic BMI (P<0.001). A 1-standard deviation increase in the PRS was associated with statistically increased risk of all-cause mortality (HR=1.06, 95% CI: 1.02, 1.11). Risks of breast cancer (HR=1.07, 95% CI: 0.96, 1.19) or CVD (HR=1.01, 95% CI: 0.90, 1.12) specific mortality did not reach statistical significance. We estimated that 27% of the PRS and all-cause mortality association was mediated by BMI (95% CI: 12%, 91%; P=0.004). Conclusions. Women with breast cancer predisposed to higher BMI were at increased risk of all-cause mortality. A BMI-related PRS may be a useful tool to identify women with breast cancer in need of additional interventions and/or surveillance. Citation Format: Clara Bodelon, Adriana Lori, Mariah Landry, James Hodge, Parichoy Pal Choudhury, Ying Wang, Lauren E. McCullough, Alpa V. Patel, Lauren R. Teras. Genetic predisposition to obesity and survival in women with breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 3425.

Polygenic score for body mass index in relation to mortality among patients with renal cell cancer

Genetically Predicted Body Mass Index and Mortality in COPD

Association of BMI, body composition and outcomes in Chinese patients with metastatic renal cell carcinoma treated with immunotherapy: A retrospective, multicohort analysis.

Abstract 3425: Genetic predisposition to obesity and survival in women with breast cancer

Association of single nucleotide polymorphisms in APOE and BMI with clinical outcome of target therapy in advanced renal cell carcinoma

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer

Body Mass Index and Survival after Cancer Diagnosis: A Pan-Cancer Cohort Study of 114 430 Patients with Cancer

The Influence of Obesity-Related Factors in the Etiology of Renal Cell Carcinoma—a Mendelian Randomization Study

Body mass index in relation to ovarian cancer survival.

Integrated Health-Related Phenotype by Polygenic Risk Scores Stratifies Risk Population for All-Cause Mortality: A Cohort Study Based on UK Biobank

Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk

Genetic Scores Based on Risk-Associated Single Nucleotide Polymorphisms (snps) Can Reveal Inherited Risk of Renal Cell Carcinoma

Abstract PR001: Highlighting the combined effects of BMI and polygenic risk score on endometrial cancer risk

Genetically Predicted High Body Mass Index is Associated with Increased Gastric Cancer Risk

Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients

Association of Body Mass Index and Body Composition with Survival in Metastatic Renal Cancer Patient Received Immunotherapy: A Multicenter, Retrospective Study

Obesity: An Independent Protective Factor For Localized Renal Cell Carcinoma In A Systemic Inflammation State

Investigating the Obesity Paradox in Colorectal Cancer: An Analysis of Prospectively Collected Data in a Diverse Cohort

Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study

Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment

The influence of body mass index on prognosis of patients with upper tract urothelial carcinoma under-went radical nephroureterectomy